Check out your Company Bowl for anonymous work chats.
We are proud to again land on Fortune’s Most Admired Companies list for 2024. The commitment and dedication of our colleagues -- not only scientists and researchers but everyone behind the scenes -- to deliver breakthroughs that change patients’ lives is worthy of recognition, and we are grateful to receive it. Pfizer is determined to build a healthier and more equitable world for patients in every corner of the globe, and we thank you for being part of our journey.
The American Cancer Society (ACS) and Pfizer Inc. (NYE: PFE) today announced the launch of “Change the Odds: Uniting to Improve Cancer Outcomes™,” a three-year initiative to bridge the gap in cancer care disparities. Through $15 million in funding from Pfizer, the initiative aims to improve health outcomes in medically underrepresented communities across the United States by enhancing awareness of and access to cancer screenings, clinical trial opportunities, and patient support and comprehensive navigation. “Change the Odds” will initially focus on breast and prostate cancer in medically underserved communities, with the potential to expand to additional cancer types. ACS plans to engage additional partners to extend the reach of the programmatic activities to more individuals and deepen the tangible impact in select communities.
To build inclusive and diverse colleague communities there must be intentional action. At Pfizer, we are proud of our efforts to create a culture where we support our colleagues and create opportunities for growth. This #BlackHistoryMonth, join us #LIVE as our colleagues Sherry Cassano, Sean Hudson and Ebony Arrington discuss how diverse voices create breakthroughs for our patients.
We are #PfizerProud of Pfizer UK for being recognised as an Inspirational STEM Employer in this year‘s #StemLearningAwards22! 👏 This year, Pfizer UK has 27 PhD studentships, 44 active apprenticeships and 92 undergraduate placements. Thank you for your continued support in inspiring individuals in STEM and providing an environment for more scientific innovations.
🏳️🌈 It's LGBTQ+ History Month in the UK and we celebrate #PfizerPride all year round. 🏳️🌈 Pfizer has been recognized for its inclusion of sexual orientation and gender identity in its inclusive practices as well as its equal opportunity policy. We also offer comprehensive coverage of same-sex domestic partners where legally permissible and transgender health care. Sponsors various LGBTQ+ nonprofits and health-focused external groups and we support the Out Pfizer Employee Network.
We’re #PfizerProud to have been certified as one of the UK’s Top Employers by the globally recognized Top Employers Institute for the 7th consecutive year, featuring in the UK top 5! 🏆 Congratulations 🎉 Pfizer UK colleagues - thank you for making Pfizer a great place to work.
It's beginning to look a lot like Christmas in the Pfizer Greece office. 🎄 As Georgia, our O2C Analyst at Pfizer says "The most beautiful things in life are not just things..they are people and places, memories and pictures..they are feelings, moments and smiles!"
Pfizer won the Employers Network for Equality and Inclusion’s “Closing the Pay Gaps Award!” 🎉 Thanks to the amazing engagement and support of all UK colleagues, and the leadership of HR at Pfizer for achieving ambitious goals and sticking to the strategy. The pay gap closed from 15.9% in 2018 to 10.2% in 2020! This is particularly impressive against a backdrop of the pay gap widening across the EU Life Science sector in 2020. Read more about our goals in the Gender Pay Gap Report.
Pfizer UK has received the Top Employer award for the sixth year in a row. It’s been a thrill to receive this recognition every year since we first took part. It certifies our excellence in six different areas of HR.
We have partnered with University of Bristol to create our new Pfizer Center of Excellence for Epidemiology of Vaccine-preventable Diseases. 🙌 This center will conduct population-based surveillance studies in hospitals & the community to identify and measure the burden of specific infectious diseases affecting both adults and children 👪 The data gathered through this new research partnership will be shared with public health bodies & scientists around the world 🌍, creating greater collaboration and informing the design, development and deployment of vaccines of the future 🔬💡
